ロード中...
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis
BACKGROUND: In 2016, the global number of individuals living with dementia was 43.8 million, representing a 117% increase from 1990—mainly due to increases in aging and population growth. Up to 90% of individuals with dementia experience neuropsychiatric symptoms (NPS). However, the limitations of c...
保存先:
| 出版年: | Can J Psychiatry |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265608/ https://ncbi.nlm.nih.gov/pubmed/31835954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0706743719892717 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|